Publications by authors named "Stephen Hyatt"

Claim this Profile
A
A Model-Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed-Dose Combination Approval in Children Living with HIV-1.
Hardik Chandasana, Ann M Buchanan, Michael McKenna, Cindy Brothers, Stephen Hyatt

J Clin Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of tertiary sulfonamides as potent liver X receptor antagonists.
William J Zuercher, Richard G Buckholz, Nino Campobasso, Jon L Collins, Cristin M Galardi, Stephen M Hyatt

J Med Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the intractability of estrogen-related receptor alpha as a target for activation by small molecules.
Stephen M Hyatt, Elizabeth L Lockamy, Rebecca A Stein, Donald P McDonnell, Aaron B Miller

J Med Chem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor.
Dow P Hurst, Diane L Lynch, Judy Barnett-Norris, Stephen M Hyatt, Herbert H Seltzman

Mol Pharmacol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis